Hodgkin lymphoma: answers take time!

被引：1

作者：

Friedberg, Jonathan W. ^{[1
]}

机构：

[1] Univ Rochester, Rochester, NY 14627 USA

来源：

BLOOD | 2011年 / 117卷 / 20期

关键词：

RADIATION-THERAPY; DISEASE;

D O I：

10.1182/blood-2011-03-340307

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：5274 / 5276

页数：5

共 10 条

[1] STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE [J].

Advani, Ranjana H. ;

Hoppe, Richard T. ;

Maeda, Lauren S. ;

Baer, David M. ;

Mason, Joseph ;

Rosenberg, Saul A. ;

Horning, Sandra J. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05) :1374-1379

[2] Involved-Nodal Radiation Therapy As a Component of Combination Therapy for Limited-Stage Hodgkin's Lymphoma: A Question of Field Size [J].

Campbell, Belinda A. ;

Voss, Nick ;

Pickles, Tom ;

Morris, James ;

Gascoyne, Randy D. ;

Savage, Kerry J. ;

Connors, Joseph M. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) :5170-5174

[3]

Connors Joseph M, 2005, Hematology Am Soc Hematol Educ Program, P239, DOI 10.1182/asheducation-2005.1.239

[4] Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma [J].

Engert, Andreas ;

Pluetschow, Annette ;

Eich, Hans Theodor ;

Lohri, Andreas ;

Doerken, Bernd ;

Borchmann, Peter ;

Berger, Bernhard ;

Greil, Richard ;

Willborn, Kay C. ;

Wilhelm, Martin ;

Debus, Juergen ;

Eble, Michael J. ;

Soekler, Martin ;

Ho, Antony ;

Rank, Andreas ;

Ganser, Arnold ;

Truemper, Lorenz ;

Bokemeyer, Carsten ;

Kirchner, Hartmut ;

Schubert, Joerg ;

Kral, Zdenek ;

Fuchs, Michael ;

Mueller-Hermelink, Hans-Konrad ;

Mueller, Rolf-Peter ;

Diehl, Volker .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (07) :640-652

[5] Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study [J].

Engert, Andreas ;

Diehl, Volker ;

Franklin, Jeremy ;

Lohri, Andreas ;

Doerken, Bernd ;

Ludwig, Wolf-Dieter ;

Koch, Peter ;

Haenel, Mathias ;

Pfreundschuh, Michael ;

Wilhelm, Martin ;

Truemper, Lorenz ;

Aulitzky, Walter-Erich ;

Bentz, Martin ;

Rummel, Mathias ;

Sezer, Orhan ;

Mueller-Hermelink, Hans-Konrad ;

Hasenclever, Dirk ;

Loeffler, Markus .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4548-4554

[6] Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease [J].

Friedberg, JW ;

Neuberg, D ;

Kim, H ;

Miyata, S ;

McCauley, M ;

Fisher, DC ;

Takvorian, T ;

Canellos, GP .

CANCER, 2003, 98 (05) :978-982

[7] Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors [J].

Ng, AK ;

Bernardo, MVP ;

Weller, E ;

Backstrand, K ;

Silver, B ;

Marcus, KC ;

Tarbell, NJ ;

Stevenson, MA ;

Friedberg, JW ;

Mauch, PM .

BLOOD, 2002, 100 (06) :1989-1996

[8] Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger [J].

Ng, AK ;

Bernardo, MP ;

Weller, E ;

Backstrand, KH ;

Silver, B ;

Marcus, KC ;

Tarbell, NJ ;

Friedberg, J ;

Canellos, GP ;

Mauch, PM .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2101-2108

[9]

RAEMAEKERS JM, 2010, P 8 INT S HODGK LYMP

[10] Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET [J].

Straus, David J. ;

Johnson, Jeffrey L. ;

LaCasce, Ann S. ;

Bartlett, Nancy L. ;

Kostakoglu, Lale ;

Hsi, Eric D. ;

Schoeder, Heiko ;

Hall, Nathan C. ;

Jung, Sin-Ho ;

Canellos, George P. ;

Schwartz, Lawrence H. ;

Takvorian, Ronald W. ;

Juweid, Malik E. ;

Cheson, Bruce D. .

BLOOD, 2011, 117 (20) :5314-5320

← 1 →